Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation

Published 2019 View Full Article

Authors

Keywords

Donor-derived CD19-targeted T cell infusion, Hematopoietic stem cell transplantation, B cell acute lymphoblastic leukemia, Minimal residual disease

Journal

Engineering

Volume -, Issue -, Pages -

Publisher

Elsevier BV

Online

2019-01-11

DOI

10.1016/j.eng.2018.12.006

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started